Oncology News and Research

RSS

Oncology, meaning bulk, mass, or tumor, and the suffix ''-logy'', meaning "study of") is a branch of medicine that deals with tumors (cancer). A medical professional who practices oncology is an ''oncologist''.

MediSens reveals full agenda to include inspiring speakers

This highly-anticipated agenda focuses on discussing a clear need to assist medical professionals in order to improve clinical outcomes, reduce dosage and control costs through advanced X-ray Imaging Systems.

31 Oct 2016

Researchers develop new way to test strength of immune response

The immune system orchestrates large and small scale attacks on innumerous targets: viruses, bacteria, cancer, but it also misfires causing allergy or autoimmune reactions.

27 Oct 2016

Biovica, Eisai sign agreement to analyze DiviTum for improved cancer drug assessment in animal models

Biovica and Eisai Inc. have entered into a lab services agreement to analyze DiviTum, an assay measuring serum thymidine kinase, for improved drug evaluation in animal cancer models.

27 Oct 2016

New Penn Medicine study raises questions about NLR as biomarker for bladder cancer

A blood test that has shown promise in predicting how cancer will progress and what treatments will be most effective for a given patient may not be reliable for either, according to a new Penn Medicine study published this week in Cancer, a peer-reviewed journal of the American Cancer Society.

27 Oct 2016

Immunotherapy drug approved by FDA as first-line treatment for non-small cell lung cancer

Pembrolizumab, an immunotherapy drug that was extensively evaluated by UCLA cancer researcher Dr. Edward Garon, has been approved by the U.S. Food & Drug Administration as first-line treatment for non-small cell lung cancer (NSCLC).

25 Oct 2016

Breakthrough Award supports research on role of chronic stress in breast cancer development

Rutgers Cancer Institute of New Jersey resident research member Wenwei Hu, PhD, has received a $596,250 Breakthrough Award from the U.S. Department of Defense through its Breast Cancer Research Program to study the role of chronic stress in breast cancer development.

25 Oct 2016

MTPConnect to provide $7.4 million funding for 14 national projects in medtech, biotech and pharmaceutical sector

MTPConnect - the Medical Technologies and Pharmaceuticals Industry Growth Centre - today announced it will provide $7.4 million of funding over two years for 14 national projects in the medtech, biotech and pharmaceutical (MTP) sector.

25 Oct 2016

Painful sex in women after cancer needs to be addressed, UC Davis researcher suggests

Painful sex in women after cancer treatment is relatively common, often treatable and needs to be addressed by medical providers, a UC Davis oncologist and researcher suggests.

25 Oct 2016

Basal tumor cell marker could help physicians personalize care for patients with bladder cancer

Tumor cells collected during the removal of a cancerous bladder and - in some cases - transplanted into mice with weakened immune systems, could help physicians rapidly identify high-risk cancers, determine prognosis and refine the use of biomarkers to personalize care for patients with this common cancer, according to a study published online on Oct. 24, 2016, in Scientific Reports.

24 Oct 2016

Danish researchers develop new method to study distribution of tracer in tumours

A Danish research team is behind a new method for studying how a tracer is distributed in a cancer tumour via its extensive vascular network.

24 Oct 2016

Myriad Genetics and ION Solutions partner to provide accurate, comprehensive hereditary cancer tests

Myriad Genetics, Inc., a global leader in personalized medicine, and ION Solutions, a part of AmerisourceBergen, and the largest physician services organization specializing in the support of community oncology, announced today that they have entered into a relationship to deliver quality hereditary cancer test results and services to ION member practices.

24 Oct 2016

Life-saving wearable technology for cancer patients secures place at Innovate 2016

A potentially life-saving technology which could dramatically impact on the lives of thousands of children and adults receiving cancer treatment has won a place at the UK’s largest innovation event - Innovate 2016.

24 Oct 2016

New study examines how tumor genome testing helps improve breast cancer treatment

A new study examines how one early example of precision medicine--tumor genome testing--is being used in women with breast cancer to reduce overtreatment and maximize the benefits of chemotherapy.

24 Oct 2016

Scientists discover new option for treating malignant pleural mesothelioma

Researchers at the Comprehensive Cancer Center of MedUni Vienna and Vienna General Hospital have discovered a new option for treating malignant pleural mesothelioma.

24 Oct 2016

Novel lipid-based therapeutic shows promise for combating drug resistance in AML

Researchers at the Medical University of South Carolina Hollings Cancer Center have discovered a mechanism that confers resistance to drugs used to treat certain types of acute myeloid leukemia (AML).

24 Oct 2016

Rearrangement of collagen linked to poor outcomes in pancreatic cancer patients

A study in the current journal Oncotarget provides the first evidence linking a disturbance of the most common protein in the body with a poor outcome in pancreatic cancer.

21 Oct 2016

Scientists modify structure of cancer drug to enhance ability to pass through blood-brain barrier

In efforts to develop new treatments for brain cancer, scientists from Johns Hopkins Drug Discovery and the Kimmel Cancer Center's Bloomberg~Kimmel Institute for Cancer Immunotherapy report they have altered the structure of an experimental drug that seems to enhance its ability to slip through the mostly impermeable blood-brain barrier.

20 Oct 2016

Einstein researchers awarded $2.6 million NIH grant to develop effective cancer immunotherapies

The National Institutes of Health has awarded two co-investigators at Albert Einstein College of Medicine a five-year, $2.6 million grant to make immunotherapy agents that more precisely and effectively treat a variety of cancers while causing far fewer side effects than current immunotherapies.

20 Oct 2016

HIIT program effective in improving aerobic performances in early-stage operable NSCLC patients

Preoperative high-intensity interval training (HIIT) in patients with resectable non-small cell lung cancer (NSCLC) improved aerobic performance in patients but failed to reduce early complications after tumor resection.

20 Oct 2016

FDA approves new therapy for initial treatment of soft tissue sarcoma

The U.S. Food and Drug Administration today granted accelerated approval to Lartruvo (olaratumab) with doxorubicin to treat adults with certain types of soft tissue sarcoma (STS), which are cancers that develop in muscles, fat, tendons or other soft tissues.

19 Oct 2016

Oncology News and Research

Further Reading

MediSens reveals full agenda to include inspiring speakers

Researchers develop new way to test strength of immune response

Biovica, Eisai sign agreement to analyze DiviTum for improved cancer drug assessment in animal models

New Penn Medicine study raises questions about NLR as biomarker for bladder cancer

Immunotherapy drug approved by FDA as first-line treatment for non-small cell lung cancer

Breakthrough Award supports research on role of chronic stress in breast cancer development

MTPConnect to provide $7.4 million funding for 14 national projects in medtech, biotech and pharmaceutical sector

Painful sex in women after cancer needs to be addressed, UC Davis researcher suggests

Basal tumor cell marker could help physicians personalize care for patients with bladder cancer

Danish researchers develop new method to study distribution of tracer in tumours

Myriad Genetics and ION Solutions partner to provide accurate, comprehensive hereditary cancer tests

Life-saving wearable technology for cancer patients secures place at Innovate 2016

New study examines how tumor genome testing helps improve breast cancer treatment

Scientists discover new option for treating malignant pleural mesothelioma

Novel lipid-based therapeutic shows promise for combating drug resistance in AML

Rearrangement of collagen linked to poor outcomes in pancreatic cancer patients

Scientists modify structure of cancer drug to enhance ability to pass through blood-brain barrier

Einstein researchers awarded $2.6 million NIH grant to develop effective cancer immunotherapies

HIIT program effective in improving aerobic performances in early-stage operable NSCLC patients

FDA approves new therapy for initial treatment of soft tissue sarcoma

Your guide to microplate readers for cancer research eBook

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Expanding access to NMR with the Fourier 80 Duo

Latest News